Volgen
Jorge R. Georgakopoulos
Jorge R. Georgakopoulos
Division of Dermatology, Department of Medicine, University of Toronto
Geverifieerd e-mailadres voor mail.utoronto.ca
Titel
Geciteerd door
Geciteerd door
Jaar
Facial and neck erythema associated with dupilumab treatment: a systematic review
CE Jo, A Finstad, JR Georgakopoulos, V Piguet, J Yeung, AM Drucker
Journal of the American Academy of Dermatology 84 (5), 1339-1347, 2021
762021
Efficacy and safety of switching to ixekizumab in secukinumab nonresponders with plaque psoriasis: a multicenter retrospective study of interleukin 17A antagonist therapies
JR Georgakopoulos, M Phung, A Ighani, J Yeung
Journal of the American Academy of Dermatology 79 (1), 155-157, 2018
522018
Drug survival of secukinumab in real-world plaque psoriasis patients: a 52-week, multicenter, retrospective study
JR Georgakopoulos, A Ighani, M Phung, J Yeung
Journal of the American Academy of Dermatology 78 (5), 1019-1020, 2018
442018
Biologic switching between interleukin 17A antagonists secukinumab and ixekizumab: a 12-week, multicenter, retrospective study.
JR Georgakopoulos, M Phung, A Ighani, K Lam, J Yeung
Journal of the European Academy of Dermatology and Venereology: JEADV 33 (1 …, 2018
322018
Efficacy and safety of secukinumab in treating moderate to severe plaque psoriasis in two real-world Canadian dermatology clinics: a multicenter retrospective study.
JR Georgakopoulos, A Ighani, LL Zhou, J Yeung
Journal of the European Academy of Dermatology and Venereology: JEADV 32 (1 …, 2017
322017
Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter …
A Ighani, JR Georgakopoulos, NH Shear, S Walsh, J Yeung
Journal of the American Academy of Dermatology 78 (4), 801-803, 2018
302018
Evaluation of long-term efficacy, safety, and reasons for discontinuation of dupilumab for moderate to severe atopic dermatitis in clinical practice: a retrospective cohort study
CE Jo, JR Georgakopoulos, M Ladda, A Ighani, A Mufti, AM Drucker, ...
Journal of the American Academy of Dermatology 82 (6), 1530-1532, 2020
292020
A comparison of apremilast monotherapy and combination therapy for plaque psoriasis in clinical practice: a Canadian multicenter retrospective study
A Ighani, JR Georgakopoulos, S Walsh, NH Shear, J Yeung
Journal of the American Academy of Dermatology 78 (3), 623-626, 2018
262018
Efficacy and safety of apremilast monotherapy for moderate to severe psoriasis: retrospective study
A Ighani, JR Georgakopoulos, LL Zhou, S Walsh, N Shear, J Yeung
Journal of Cutaneous Medicine and Surgery 22 (3), 290-296, 2018
232018
Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: a Canadian multicenter retrospective study
JR Georgakopoulos, A Mufti, R Vender, J Yeung
Journal of the American Academy of Dermatology 83 (4), 1212-1214, 2020
222020
Ixekizumab (interleukin 17A antagonist): 12-week efficacy and safety outcomes in real-world clinical practice
JR Georgakopoulos, M Phung, A Ighani, J Yeung
Journal of Cutaneous Medicine and Surgery 23 (2), 174-177, 2019
192019
Secukinumab dose optimization in adult psoriasis patients: a retrospective, multicenter case series
M Phung, JR Georgakopoulos, A Ighani, L Giroux, J Yeung
JAAD Case Reports 4 (4), 310-313, 2018
192018
Systemic monotherapy treatments for generalized pustular psoriasis: a systematic review
LL Zhou, JR Georgakopoulos, A Ighani, J Yeung
Journal of Cutaneous Medicine and Surgery 22 (6), 591-601, 2018
182018
Short-and long-term management of an acute pustular psoriasis flare: a case report
JR Georgakopoulos, A Ighani, J Yeung
Journal of Cutaneous Medicine and Surgery 21 (5), 452-456, 2017
182017
Long-term dupilumab treatment for chronic refractory generalized prurigo nodularis: A retrospective cohort study
JR Georgakopoulos, D Croitoru, T Felfeli, R Alhusayen, P Lansang, ...
Journal of the American Academy of Dermatology 85 (4), 1049-1051, 2021
172021
The chemoattractant potential of ginsenosides in the ginseng–Pythium irregulare pathosystem
DA Ivanov, JRC Georgakopoulos, MA Bernards
Phytochemistry 122, 56-64, 2016
172016
Numerous asymptomatic dermal cysts: diagnosis and treatment of steatocystoma multiplex
JR Georgakopoulos, A Ighani, J Yeung
Canadian Family Physician 64 (12), 892-899, 2018
152018
Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: a real-world Canadian multicenter retrospective study
JR Georgakopoulos, T Felfeli, AM Drucker, CE Jo, V Piguet, J Yeung
JAAD international 4, 67, 2021
142021
Patient-driven discontinuation of dupilumab during the COVID-19 pandemic in two academic hospital clinics at the University of Toronto
JR Georgakopoulos, J Yeung
Journal of Cutaneous Medicine and Surgery 24 (4), 422-423, 2020
132020
Incidence of COVID-19 in patients with chronic idiopathic urticaria and asthma on omalizumab: a multicentre retrospective cohort study
A Abduelmula, JR Georgakopoulos, A Mufti, AR Devani, MJ Gooderham, ...
Journal of cutaneous medicine and surgery 26 (3), 319-320, 2022
122022
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20